News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Acambis PLC’s Universal Influenza Vaccine Enters Phase 1 Trial
July 17, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Cambridge, UK and Cambridge, Massachusetts – 17 July 2007 – Acambis plc (Acambis) (LSE: ACM), a leading vaccines company, announces that it has initiated a Phase 1 clinical trial of its universal influenza vaccine candidate, ACAM-FLU-A.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase I
Europe
MORE ON THIS TOPIC
Cystic fibrosis
Arcturus Plunges on ‘Mixed’ Cystic Fibrosis Data for Inhaled mRNA Drug
October 23, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Moderna Scraps CMV Vaccine After Phase III Fail
October 23, 2025
·
3 min read
·
Tristan Manalac
Cancer
ADC, Bispecifics and Kinase Blockers Steal the Spotlight at ESMO 2025 in Berlin
October 22, 2025
·
4 min read
·
Tristan Manalac
Obesity
Terns Turns Away From Obesity Pill After ‘Uncompetitive’ Phase II Profile
October 22, 2025
·
2 min read
·
Tristan Manalac
